4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Changmao Biochemical Engineering Company Limited (0954) operates in the Specialty Chemicals industry and is headquartered in Changzhou, China with about 507 employees. Its market capitalization is roughly CNY 131 million. In the fiscal year ended 2025-12-31, 0954 reported CNY 557M in revenue and (CNY 67M) in net income.
Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 557M | CNY 585M | CNY 637M | CNY 730M | — |
| Gross Profit | CNY 18M | CNY 17M | CNY 26M | CNY 181M | — |
| Operating Income (EBIT) | (CNY 52M) | (CNY 58M) | (CNY 51M) | CNY 87M | — |
| Net Income | (CNY 67M) | (CNY 68M) | (CNY 86M) | CNY 81M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | (CNY 42M) | — | (CNY 11M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.2B | CNY 1.2B | CNY 1.2B | CNY 1.2B | — |
| Total Liabilities | CNY 664M | CNY 666M | CNY 591M | CNY 428M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0954 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms